Feasibility, safety, and outcome of recanalization treatment in childhood stroke

作者：Bigi Sandra^*; Dulcey Andrea; Gralla Jan; Bernasconi Corrado; Melliger Amber; Datta Alexandre N; Arnold Marcel; Kaesmacher Johannes; Fluss Joel; Hackenberg Annette; Maier Oliver; Weber Johannes; Poloni Claudia; Fischer Urs; Steinlin Maja

来源：Annals of Neurology, 2018, 83(6): 1125-1132.

DOI：10.1002/ana.25242

ObjectiveIntravenous thrombolysis and endovascular therapy (IVT/EVT) are evidence-based treatments for adults with arterial ischemic stroke (AIS). However, randomized controlled trials in pediatric patients are lacking. This study aimed to describe feasibility, safety, and outcome of IVT/EVT in children with AIS.
MethodsThis retrospective study (01/2000-12/2015) included a multicenter, population-based consecutive cohort of patients aged 1 month to 16 years, diagnosed with AIS and presenting with pediatric National Institutes of Health Stroke Scale (pedNIHSS)4. Clinical and radiological data of patients receiving IVT/EVT were compared to those receiving standard care (SC) using linear regression to adjust for potential confounders. EVT included intra-arterial thrombolysis and/or mechanical thrombectomy. Outcome was assessed 6 months after stroke using the pediatric stroke outcome measure (PSOM).
ResultsOverall, 150 patients (age 7.14.9 years, 55 [37%] females) presented with pedNIHSS4. Recanalization treatment was performed in 16 (11%), of whom 5 (3%) were treated with IVT and 11 (7%) with EVT. Patients receiving recanalization treatment were older (mean age=11.0 vs 6.9 years, p=0.01) and more severely affected (median pedNIHSS=13.5 vs 8.0, p<0.001). Death and bleeding complications did not differ between the 2 groups. Median (interquartile range) PSOM 6 months after AIS was 2.5 (1-4.3) and 1 (0-2) in the IVT/EVT and SC groups, respectively (p=0.014). However, after multiple linear regression analysis, only higher baseline pedNIHSS remained associated with an unfavorable outcome (p<0.001).
InterpretationRecanalization treatment is feasible and seems to be safe in severely affected pediatric AIS patients. The assessment of efficacy of IVT/EVT in pediatric stroke patients requires larger studies. Ann Neurol 2018;83:1125-1132

• 出版日期2018-6